Author:
Wang Yansu,Liu Ming,Liu Xiaoqian,Guo Xianling
Abstract
Abstract
Background
The ubiquitin protein ligase E3C (UBE3C) has been reported to play an oncogenic role in breast cancer (BRCA). This work further investigates the effect of UBE3C on the radioresistance of BRCA cells.
Methods
Molecules linking to radioresistance in BRCA were identified by analyzing two GEO datasets, GSE31863 and GSE101920. UBE3C overexpression or knockdown was induced in parental or radioresistant BRCA cells, followed by irradiation treatment. The malignant properties of cells in vitro, and the growth and metastatic activity of cells in nude mice, were analyzed. Downstream target proteins, as well as upstream transcriptional regulators of UBE3C, were predicted by bioinformatics tools. Molecular interactions were confirmed by immunoprecipitation and immunofluorescence assays. Furthermore, artificial alterations of TP73 and FOSB were induced in the BRCA cells for functional rescue assays.
Results
According to bioinformatics analyses, UBE3C expression was linked to radioresistance in BRCA. UBE3C knockdown in radioresistant BRCA cells reduced while its overexpression in parental BRCA cells increased the radioresistance of cells in vitro and in vivo. UBE3C, which induced ubiquitination-dependent protein degradation of TP73, was transcriptionally activated by FOSB. The radioresistance of cancer cells was blocked by TP73 overexpression or FOSB knockdown. Additionally, LINC00963 was found to be responsible for the recruitment of FOSB to the UBE3C promoter for transcription activation.
Conclusion
This work demonstrates that LINC00963 induces nuclear translocation of FOSB and the consequent transcription activation of UBE3C, which enhances radioresistance of BRCA cells by inducing ubiquitination-dependent protein degradation of TP73.
Graphical Abstract
Funder
National Natural Science Foundation of China
Shanghai Municipal Health Commission
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference40 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
2. Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, Henley SJ, Anderson RN, Firth AU, Ma J, Kohler BA, Jemal A. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2018;124(13):2785–800.
3. F.K. Al-Thoubaity, Molecular classification of breast cancer: a retrospective cohort study. Ann Med Surg (Lond). 2020;49:44–48.
4. Nounou MI, ElAmrawy F, Ahmed N, Abdelraouf K, Goda S. Syed-Sha-Qhattal 2015. breast Cancer: conventional diagnosis and treatment modalities and recent patents and technologies. Breast Cancer (Auckl). 9: 17–34.
5. Y.J. Kim, S.S. Kim, S.D. Ahn, J. Jung, S.H. Ahn, B.H. Son, J.W. Lee, H.J. Kim, B.S. Ko, S.B. Kim, K.H. Jung, J.H. Ahn, J.E. Kim, E.K. Choi, The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer. Asia Pac J Clin Oncol. 2021;17(6):495–505.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献